Hu Shi-Si, Ding Hui, Meng Xu-Yun, Ouyang Bo-Wen, Yang Zhen-Duo, Chen Xiao-Dan, Zhong Xing-Wu
Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou 570311, Hainan Province, China.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, Guangdong Province, China.
Int J Ophthalmol. 2024 Dec 18;17(12):2221-2228. doi: 10.18240/ijo.2024.12.09. eCollection 2024.
To evaluate the clinical efficacy and feasibility of superficial corneal opacities treated by excimer laser phototherapeutic keratectomy (PTK) combined with small incision lenticule extraction (SMILE)-derived corneal stromal lenticule transplantation.
A retrospective interventional case series of nine patients aged 12-59y with superficial corneal opacity caused by different pathologies who underwent standardized PTK combined with SMILE-derived corneal stromal lenticule transplantation was examined. Lenticule patches were fixed with fibrin glue. All patients underwent pre- and post-operative clinical assessments at different times for up to 12mo. Slit lamp microscopy, corneal density, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and anterior segment optical coherence tomography (AS-OCT) were examined.
The patients' mean age was 36.00±5.80 (12-59)y. Seven eyes (77.8%) gained UDVA and CDVA at the last measurement compared to their preoperative levels. The densities of the total cornea, the total anterior corneal layer, and the anterior corneal layers of 0-2 and 2-6 mm decreased significantly by 12.4%, 27.5%, 46.7%, and 32.8%, respectively. After human allogeneic transplantation, the implanted lenticules of all eyes were clearly visible by AS-OCT and remained transparent without displacement or graft rejection. The thickness of the central cornea and corneal lenticule transplants were stable throughout the entire postoperative period. One case experienced the postoperative complication of delayed corneal epithelial healing.
PTK combined with SMILE-derived corneal lenticule transplantation improves long-term visual acuity. Therefore, it is a new, safe, and effective method for treating superficial corneal opacity.
评估准分子激光角膜切削术(PTK)联合小切口基质透镜切除术(SMILE)衍生的角膜基质透镜移植治疗浅层角膜混浊的临床疗效和可行性。
回顾性分析9例年龄在12 - 59岁因不同病因导致浅层角膜混浊的患者,他们接受了标准化的PTK联合SMILE衍生的角膜基质透镜移植。透镜片用纤维蛋白胶固定。所有患者在术后长达12个月的不同时间进行术前和术后临床评估。检查裂隙灯显微镜、角膜密度、未矫正远视力(UDVA)、矫正远视力(CDVA)和眼前节光学相干断层扫描(AS - OCT)。
患者的平均年龄为36.00±5.80(12 - 59)岁。与术前水平相比,最后一次测量时7只眼(77.8%)的UDVA和CDVA提高。全角膜、角膜前层总厚度以及0 - 2 mm和2 - 6 mm角膜前层的密度分别显著降低了12.4%、27.5%、46.7%和32.8%。人同种异体移植后,所有眼植入的透镜通过AS - OCT清晰可见,保持透明,无移位或移植排斥反应。整个术后期间中央角膜厚度和角膜透镜移植厚度稳定。1例出现角膜上皮愈合延迟的术后并发症。
PTK联合SMILE衍生的角膜透镜移植可提高长期视力。因此,它是一种治疗浅层角膜混浊的新的、安全有效的方法。